Topics

An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future.  http://bit.ly/2OOUuki pic.twitter.com/QTvTWBWdnM

17:00 EST 4 Dec 2019 | PhRMA

An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future.  http://bit.ly/2OOUuki 

Original Article: An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future.  http://bit.ly/2OOUuki pic.twitter.com/QTvTWBWdnM

NEXT ARTICLE

More From BioPortfolio on "An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future.  http://bit.ly/2OOUuki pic.twitter.com/QTvTWBWdnM"

Quick Search